Women represent 51% of the population; not investing is a poor investment strategy. Incorporating women into leadership positions, into board rooms, is the only way to tap this market.
 
Host
<a href="https://www.linkedin.com/in/lorielliskatz/" rel="ugc noopener noreferrer" target="_blank">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a>, Head of Insights, BioSpace
 
Guests
<a href="https://www.linkedin.com/in/konstantina-katcheves-3757236/" rel="ugc noopener noreferrer" target="_blank">⁠Konstantina Katcheves⁠</a>, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
<a href="https://www.linkedin.com/in/sanskritithakur/" rel="ugc noopener noreferrer" target="_blank">⁠Sanskriti Thakur⁠</a>, Chairwoman, TOWER Capital Group

BridgeBio’s ATTR-CM Approval, Cassava’s Alzheimer’s Failure, Trump’s Cabinet Picks, More

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.